{"id":"NCT03215706","sponsor":"Bristol-Myers Squibb","briefTitle":"A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC","officialTitle":"A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-24","primaryCompletion":"2019-08-16","completion":"2024-10-18","firstPosted":"2017-07-12","resultsPosted":"2020-09-16","lastUpdate":"2024-12-24"},"enrollment":719,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Ipilimumab","otherNames":["Yervoy, BMS734016"]},{"type":"BIOLOGICAL","name":"Nivolumab","otherNames":["Opdivo, BMS936558"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Taxol"]},{"type":"DRUG","name":"Pemetrexed","otherNames":["Alimta"]},{"type":"DRUG","name":"Cisplatin","otherNames":["Platinol"]}],"arms":[{"label":"Module A","type":"EXPERIMENTAL"},{"label":"Module B","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization to date of death (assessed up to October 2019, approximately 23 months)","effectByArm":[{"arm":"Treatment A","deltaMin":14.13,"sd":null},{"arm":"Treatment B","deltaMin":10.74,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0006"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":116,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","China","France","Germany","Ireland","Italy","Japan","Mexico","Poland","Romania","Russia","Spain","United Kingdom"]},"refs":{"pmids":["39369790","39270380","33476593"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSClinicalTrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":203,"n":358},"commonTop":["Anaemia","Nausea","Asthenia","Decreased appetite","Diarrhoea"]}}